Alnylam Pharmaceuticals · 2 weeks ago
Director, Cyber Architecture & Engineering
United States
Full-time
Remote
Director/Executive
$200K/yr - $270K/yr
10+ years expAlnylam Pharmaceuticals is pioneering RNA interference therapeutics and is seeking a Director of Cybersecurity Architecture to define and drive the security architecture strategy. This role involves owning the cyber architecture, translating strategy into actionable standards, and ensuring security is integrated into enterprise initiatives.
BiotechnologyHealthcarePharmaceuticalHealth CareMedicalTherapeutics
Responsibilities
Define and own Alnylam’s enterprise cybersecurity architecture and target state aligned to business growth, regulatory requirements, and risk appetite
Lead the design and evolution of a Zero Trust architecture, emphasizing identity, least privilege, segmentation, and continuous verification
Establish and maintain cyber reference architectures, design patterns, and standards across identity, cloud, applications, data, infrastructure, and endpoints
Serve as the senior security architecture authority for major enterprise initiatives, ensuring security is embedded early and consistently
Partner with Information Technology and Expertise Areas to align cybersecurity architecture with broader technology strategy and prevent fragmented or duplicative solutions
Responsible for engineering execution that turns strategy into resilient, enterprise‑grade security capabilities
Drive architectural input into vendor selection, platform strategy, and solution design, balancing risk reduction with business enablement
Establish governance for architecture reviews, risk-based exceptions, and technical debt remediation
Translate cybersecurity strategy into multi-year roadmaps with clear milestones, dependencies, and measurable outcomes
Define and track architecture-related metrics demonstrating risk reduction, consistency, and maturity progression
Lead, mentor, and grow a team of security architects and engineers, fostering a culture of accountability and strong partnership
Qualification
Required
Bachelor's degree in computer science, information security, engineering, or related field
10+ years of progressive experience in cybersecurity, security architecture, or enterprise technology design, with 8+ years of leadership experience, including building and leading architecture or engineering teams
Deep expertise in designing security architecture across IAM, cloud/hybrid environments, application and API security, network segmentation/Zero Trust, and data protection
Strong familiarity with cybersecurity frameworks and standards (e.g., NIST CSF, NIST 800-53, Zero Trust Architecture concepts)
Demonstrated ability to influence senior stakeholders and drive architectural decisions across complex, regulated environments
Proven record of balancing strategic vision with practical execution in fast-moving organizations
Excellent communication skills, translating complex technical concepts into clear business impact
Preferred
Master's degree or MBA preferred
Industry-recognized certifications strongly preferred (e.g., CISSP, CCSP, SABSA, TOGAF, or equivalent)
Benefits
Comprehensive benefits including medical, dental, and vision coverage
Life and disability insurance
A lifestyle reimbursement program
Flexible spending and health savings accounts
401(k) with a generous company match
Paid time off
Wellness days
Holidays
Two company-wide recharge breaks
Generous family resources and leave
Company
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization.
1001-5000 employees
H1B Sponsorship
Alnylam Pharmaceuticals has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
75%
Represents job field similar to this job
Engineering and Development
Management and Executive
Legal and Compliance
Customer Service and Support
Trends of Total Sponsorships
*2022 (18)
2021 (19)
2020 (7)
Funding
Current Stage
Public CompanyTotal Funding
$4.55BKey Investors
Blackstone Life SciencesBlackstone CreditRegeneron
2025-09-09Post Ipo Debt· $661.25M
2022-09-12Post Ipo Debt· $900M
2022-03-04IPO
Leadership Team
Yvonne Greenstreet
Chief Executive Officer
Jeff Poulton
Chief Financial Officer
Recent News
Company data provided by crunchbase